Aurobindo Pharma arm gets USFDA nod for Azacitidine for Injection to treat myelodysplastic syndrome Ruchika Sharma4 Jan 2023 11:07 AM ISTThe product is indicated for the treatment of adult patients with the following FAB myelodysplastic syndrome (MDS) subtypes.
GSK, Sanofi, Pfizer and other drugmakers plan to raise prices on at least 350 drugs in US in January Ruchika Sharma31 Dec 2022 1:15 PM ISTTo date, Pfizer announced the most increases, with prices rising on 89 unique drug brands, and an additional increase on 10 drug brands at its Hospira...
Multiple myeloma drug case: Dr Reddy Labs gets legal respite in US Ruchika Sharma29 Dec 2022 4:30 PM ISTNew Delhi: Drugmaker, Dr Reddy's Laboratories has announced that all claims against it in the antitrust litigation filed in the US, related to a...
Shared Monopoly in sale of generic Revlimid: Dr Reddy's Labs, Bristol Myers Squibb and others face anti-trust litigation in US Ruchika Sharma23 Nov 2022 11:52 AM ISTThe company said the complaint "alleges that the challenged agreements improperly delayed generic entry entirely until 2022 and then improperly...
US Supreme Court rejects Bristol Myers cancer drug Yescarta patent fight with Gilead Sciences Ruchika Sharma8 Nov 2022 4:30 PM ISTA Gilead spokesperson said the company was pleased with the Supreme Court's decision, which has "effectively ended" the dispute.
Bristol Myers Squibb bags USFDA approval for plaque psoriasis oral treatment Sotyktu Ruchika Sharma12 Sept 2022 1:29 PM ISTPsoriasis is a widely prevalent, chronic, systemic immune-mediated disease.
Cipla Cancer drug Lenalidomide bags USFDA okay Ruchika Sharma7 Sept 2022 4:22 PM ISTMumbai: Drugmaker, Cipla Limited, today announced that the company has received final approval for its Abbreviated New Drug Application (ANDA) for...
Setback: Bristol Myers drug combo fails to meet main goal in kidney cancer trial Ruchika Sharma30 July 2022 1:15 PM ISTRenal cell carcinoma (RCC) is the most common type of kidney cancer in adults
Bristol Myers Squibb bags USFDA nod for CAR T Cell Therapy Breyanzi Ruchika Sharma26 Jun 2022 4:00 PM ISTBreyanzi, a differentiated CAR T cell therapy, is made from a patient's own T cells, which are collected and genetically reengineered to become CAR T...
Bristol Myers Squibb must face USD 6.4 billion lawsuit over delayed cancer drug Ruchika Sharma25 Jun 2022 3:30 PM ISTThe case arose from the company's agreement to pay Celgene shareholders holding "contingent value rights" an extra $9 per share in cash if it won U.S....
USFDA nod to Alembic Pharma cancer drug Dasatinib Ruchika Sharma10 Jun 2022 12:58 PM ISTVadodara: Drugmaker, Alembic Pharmaceuticals Limited, today announced that the company has received tentative approval from the US Food & Drug...
Bristol Myers Squibb withdraws supplemental biologics license application for Reblozyl for Non-transfusion Dependent (NTD) Beta Thalassemia Ruchika Sharma5 Jun 2022 5:00 PM ISTReblozyl, a first-in-class therapeutic option, is currently approved in the United States, European Union and Canada to address transfusion-dependent...
